{"transactions":[{"id":3958644,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":167356,"kind":"organization","name":"LV Management Group, LLC","position":1,"cik":"0001681884","reported_name":"LV Management Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12397,"kind":"organization","name":"Lilly Ventures Fund I LLC","position":2,"cik":"0001575852","reported_name":"Lilly Ventures Fund I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12659,"kind":"person","name":"Torres S. Edward","position":3,"cik":"0001552293","reported_name":"Torres S. Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138131,"kind":"person","name":"Hall Steven Edward","position":4,"cik":"0001602732","reported_name":"Hall Steven Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-04-23T16:16:47.000Z","date":"2018-04-23","kind":"exercise","acquired":false,"shares":7000000,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock automatically converted into the Issuer's common stock on a 2.2-for-1 basis at the closing of the Issuer's initial public\noffering without payment or further consideration and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock automatically converted into the Issuer's common stock on a 2.2-for-1 basis at the closing of the Issuer's initial public\noffering without payment or further consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock automatically converted into the Issuer's common stock on a 2.2-for-1 basis at the closing of the Issuer's initial public\noffering without payment or further consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock automatically converted into the Issuer's common stock on a 2.2-for-1 basis at the closing of the Issuer's initial public\noffering without payment or further consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Lilly Ventures Fund I, LLC (LVFI). LV Management Group, LLC (LVMG) is the management company for LVFI\nand has voting and dispositive power over the shares held by LVFI. As such, LVMG may be deemed to indirectly beneficially own the shares\nheld by LVFI. LVMG's voting and dispositive decisions with respect to the shares held by LVFI are made by LVMG's management committee,\nwhich consists of S. Edward Torres, Dr. Steven E. Hall and Dr. Armen B. Shanafelt. Each of the individuals and entities listed above expressly disclaims\nbeneficial ownership of the shares held by LVFI, except to the extent of his or its pecuniary interest therein. Dr. Shanafelt is a director of the\nIssuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3181817},"source":{"system":"sec-edgar","filing":"0001209191-18-025824","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919118025824/doc4.xml","form_type":"4"}},{"id":3958643,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":167356,"kind":"organization","name":"LV Management Group, LLC","position":1,"cik":"0001681884","reported_name":"LV Management Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12397,"kind":"organization","name":"Lilly Ventures Fund I LLC","position":2,"cik":"0001575852","reported_name":"Lilly Ventures Fund I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12659,"kind":"person","name":"Torres S. Edward","position":3,"cik":"0001552293","reported_name":"Torres S. Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138131,"kind":"person","name":"Hall Steven Edward","position":4,"cik":"0001602732","reported_name":"Hall Steven Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-23T16:16:47.000Z","date":"2018-04-23","kind":"purchase","acquired":true,"shares":266000,"price":15,"value":3990000.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Lilly Ventures Fund I, LLC (LVFI). LV Management Group, LLC (LVMG) is the management company for LVFI\nand has voting and dispositive power over the shares held by LVFI. As such, LVMG may be deemed to indirectly beneficially own the shares\nheld by LVFI. LVMG's voting and dispositive decisions with respect to the shares held by LVFI are made by LVMG's management committee,\nwhich consists of S. Edward Torres, Dr. Steven E. Hall and Dr. Armen B. Shanafelt. Each of the individuals and entities listed above expressly disclaims\nbeneficial ownership of the shares held by LVFI, except to the extent of his or its pecuniary interest therein. Dr. Shanafelt is a director of the\nIssuer and, accordingly, files separate Section 16 reports."}],"balance_after":3447817,"source":{"system":"sec-edgar","filing":"0001209191-18-025824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919118025824/doc4.xml","form_type":"4"}},{"id":3958642,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":167356,"kind":"organization","name":"LV Management Group, LLC","position":1,"cik":"0001681884","reported_name":"LV Management Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12397,"kind":"organization","name":"Lilly Ventures Fund I LLC","position":2,"cik":"0001575852","reported_name":"Lilly Ventures Fund I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12659,"kind":"person","name":"Torres S. Edward","position":3,"cik":"0001552293","reported_name":"Torres S. Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138131,"kind":"person","name":"Hall Steven Edward","position":4,"cik":"0001602732","reported_name":"Hall Steven Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-23T16:16:47.000Z","date":"2018-04-23","kind":"exercise","acquired":true,"shares":3181817,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock automatically converted into the Issuer's common stock on a 2.2-for-1 basis at the closing of the Issuer's initial public\noffering without payment or further consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Lilly Ventures Fund I, LLC (LVFI). LV Management Group, LLC (LVMG) is the management company for LVFI\nand has voting and dispositive power over the shares held by LVFI. As such, LVMG may be deemed to indirectly beneficially own the shares\nheld by LVFI. LVMG's voting and dispositive decisions with respect to the shares held by LVFI are made by LVMG's management committee,\nwhich consists of S. Edward Torres, Dr. Steven E. Hall and Dr. Armen B. Shanafelt. Each of the individuals and entities listed above expressly disclaims\nbeneficial ownership of the shares held by LVFI, except to the extent of his or its pecuniary interest therein. Dr. Shanafelt is a director of the\nIssuer and, accordingly, files separate Section 16 reports."}],"balance_after":3181817,"source":{"system":"sec-edgar","filing":"0001209191-18-025824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919118025824/doc4.xml","form_type":"4"}},{"id":4260828,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":167356,"kind":"organization","name":"LV Management Group, LLC","position":1,"cik":"0001681884","reported_name":"LV Management Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":12397,"kind":"organization","name":"Lilly Ventures Fund I LLC","position":2,"cik":"0001575852","reported_name":"Lilly Ventures Fund I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":12659,"kind":"person","name":"Torres S. Edward","position":3,"cik":"0001552293","reported_name":"Torres S. Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":138131,"kind":"person","name":"Hall Steven Edward","position":4,"cik":"0001602732","reported_name":"Hall Steven Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Series F Preferred Stock","published_at":"2017-07-07T23:16:02.000Z","date":"2017-07-05","kind":"exercise","acquired":false,"shares":1443972,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Lilly Ventures Fund I, LLC (LVFI). LV Management Group, LLC (LVMG) is the management company for LVFI and has voting and dispositive power over the shares held by LVFI. As such, LVMG may be deemed to indirectly beneficially own the shares held by LVFI. LVMG's voting and dispositive decisions with respect to the shares held by LVFI are made by LVMG's management committee, which consists of Ed Torres, Dr. Steve Hall and Armen B. Shanafelt. Each of the individuals and entities listed above expressly disclaims beneficial ownership of the shares held by LVFI, except to the extent of his or its respective pecuniary interest therein. Dr. Shanafelt is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":145312},"source":{"system":"sec-edgar","filing":"0000899243-17-018092","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317018092/doc4.xml","form_type":"4"}},{"id":4260827,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":167356,"kind":"organization","name":"LV Management Group, LLC","position":1,"cik":"0001681884","reported_name":"LV Management Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":12397,"kind":"organization","name":"Lilly Ventures Fund I LLC","position":2,"cik":"0001575852","reported_name":"Lilly Ventures Fund I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":12659,"kind":"person","name":"Torres S. Edward","position":3,"cik":"0001552293","reported_name":"Torres S. Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":138131,"kind":"person","name":"Hall Steven Edward","position":4,"cik":"0001602732","reported_name":"Hall Steven Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Series E-3 Preferred Stock","published_at":"2017-07-07T23:16:02.000Z","date":"2017-07-05","kind":"exercise","acquired":false,"shares":1654411,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Lilly Ventures Fund I, LLC (LVFI). LV Management Group, LLC (LVMG) is the management company for LVFI and has voting and dispositive power over the shares held by LVFI. As such, LVMG may be deemed to indirectly beneficially own the shares held by LVFI. LVMG's voting and dispositive decisions with respect to the shares held by LVFI are made by LVMG's management committee, which consists of Ed Torres, Dr. Steve Hall and Armen B. Shanafelt. Each of the individuals and entities listed above expressly disclaims beneficial ownership of the shares held by LVFI, except to the extent of his or its respective pecuniary interest therein. Dr. Shanafelt is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":166489},"source":{"system":"sec-edgar","filing":"0000899243-17-018092","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317018092/doc4.xml","form_type":"4"}},{"id":4260826,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":167356,"kind":"organization","name":"LV Management Group, LLC","position":1,"cik":"0001681884","reported_name":"LV Management Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":12397,"kind":"organization","name":"Lilly Ventures Fund I LLC","position":2,"cik":"0001575852","reported_name":"Lilly Ventures Fund I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":12659,"kind":"person","name":"Torres S. Edward","position":3,"cik":"0001552293","reported_name":"Torres S. Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":138131,"kind":"person","name":"Hall Steven Edward","position":4,"cik":"0001602732","reported_name":"Hall Steven Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Series E-2 Preferred Stock","published_at":"2017-07-07T23:16:02.000Z","date":"2017-07-05","kind":"exercise","acquired":false,"shares":1907373,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Lilly Ventures Fund I, LLC (LVFI). LV Management Group, LLC (LVMG) is the management company for LVFI and has voting and dispositive power over the shares held by LVFI. As such, LVMG may be deemed to indirectly beneficially own the shares held by LVFI. LVMG's voting and dispositive decisions with respect to the shares held by LVFI are made by LVMG's management committee, which consists of Ed Torres, Dr. Steve Hall and Armen B. Shanafelt. Each of the individuals and entities listed above expressly disclaims beneficial ownership of the shares held by LVFI, except to the extent of his or its respective pecuniary interest therein. Dr. Shanafelt is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":191946},"source":{"system":"sec-edgar","filing":"0000899243-17-018092","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317018092/doc4.xml","form_type":"4"}},{"id":4260825,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":167356,"kind":"organization","name":"LV Management Group, LLC","position":1,"cik":"0001681884","reported_name":"LV Management Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":12397,"kind":"organization","name":"Lilly Ventures Fund I LLC","position":2,"cik":"0001575852","reported_name":"Lilly Ventures Fund I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":12659,"kind":"person","name":"Torres S. Edward","position":3,"cik":"0001552293","reported_name":"Torres S. Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":138131,"kind":"person","name":"Hall Steven Edward","position":4,"cik":"0001602732","reported_name":"Hall Steven Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Series D Preferred Stock","published_at":"2017-07-07T23:16:02.000Z","date":"2017-07-05","kind":"exercise","acquired":false,"shares":3390885,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Lilly Ventures Fund I, LLC (LVFI). LV Management Group, LLC (LVMG) is the management company for LVFI and has voting and dispositive power over the shares held by LVFI. As such, LVMG may be deemed to indirectly beneficially own the shares held by LVFI. LVMG's voting and dispositive decisions with respect to the shares held by LVFI are made by LVMG's management committee, which consists of Ed Torres, Dr. Steve Hall and Armen B. Shanafelt. Each of the individuals and entities listed above expressly disclaims beneficial ownership of the shares held by LVFI, except to the extent of his or its respective pecuniary interest therein. Dr. Shanafelt is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":341238},"source":{"system":"sec-edgar","filing":"0000899243-17-018092","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317018092/doc4.xml","form_type":"4"}},{"id":4260824,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":167356,"kind":"organization","name":"LV Management Group, LLC","position":1,"cik":"0001681884","reported_name":"LV Management Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":12397,"kind":"organization","name":"Lilly Ventures Fund I LLC","position":2,"cik":"0001575852","reported_name":"Lilly Ventures Fund I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":12659,"kind":"person","name":"Torres S. Edward","position":3,"cik":"0001552293","reported_name":"Torres S. Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":138131,"kind":"person","name":"Hall Steven Edward","position":4,"cik":"0001602732","reported_name":"Hall Steven Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Common Stock","published_at":"2017-07-07T23:16:02.000Z","date":"2017-07-05","kind":"purchase","acquired":true,"shares":250000,"price":15,"value":3750000.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Lilly Ventures Fund I, LLC (LVFI). LV Management Group, LLC (LVMG) is the management company for LVFI and has voting and dispositive power over the shares held by LVFI. As such, LVMG may be deemed to indirectly beneficially own the shares held by LVFI. LVMG's voting and dispositive decisions with respect to the shares held by LVFI are made by LVMG's management committee, which consists of Ed Torres, Dr. Steve Hall and Armen B. Shanafelt. Each of the individuals and entities listed above expressly disclaims beneficial ownership of the shares held by LVFI, except to the extent of his or its respective pecuniary interest therein. Dr. Shanafelt is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1094987,"source":{"system":"sec-edgar","filing":"0000899243-17-018092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317018092/doc4.xml","form_type":"4"}},{"id":4260823,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":167356,"kind":"organization","name":"LV Management Group, LLC","position":1,"cik":"0001681884","reported_name":"LV Management Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":12397,"kind":"organization","name":"Lilly Ventures Fund I LLC","position":2,"cik":"0001575852","reported_name":"Lilly Ventures Fund I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":12659,"kind":"person","name":"Torres S. Edward","position":3,"cik":"0001552293","reported_name":"Torres S. Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":138131,"kind":"person","name":"Hall Steven Edward","position":4,"cik":"0001602732","reported_name":"Hall Steven Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Common Stock","published_at":"2017-07-07T23:16:02.000Z","date":"2017-07-05","kind":"exercise","acquired":true,"shares":844987,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Lilly Ventures Fund I, LLC (LVFI). LV Management Group, LLC (LVMG) is the management company for LVFI and has voting and dispositive power over the shares held by LVFI. As such, LVMG may be deemed to indirectly beneficially own the shares held by LVFI. LVMG's voting and dispositive decisions with respect to the shares held by LVFI are made by LVMG's management committee, which consists of Ed Torres, Dr. Steve Hall and Armen B. Shanafelt. Each of the individuals and entities listed above expressly disclaims beneficial ownership of the shares held by LVFI, except to the extent of his or its respective pecuniary interest therein. Dr. Shanafelt is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":844987,"source":{"system":"sec-edgar","filing":"0000899243-17-018092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317018092/doc4.xml","form_type":"4"}},{"id":178837,"issuer":{"id":12658,"kind":"organization","name":"Receptos, Inc.","symbol":"RCPT"},"owners":[{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY","position":1,"cik":"0000059478","reported_name":"LILLY ELI & CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12397,"kind":"organization","name":"Lilly Ventures Fund I LLC","position":2,"cik":"0001575852","reported_name":"Lilly Ventures Fund I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12659,"kind":"person","name":"Torres S. Edward","position":3,"cik":"0001552293","reported_name":"Torres S. Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2013-11-21T22:23:39.000Z","date":"2013-05-14","kind":"exercise","acquired":false,"price":0,"reported_value":5040221,"ownership":{"direct":false,"nature":"by Group"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Series A preferred stock and Series B preferred stock converted upon the closing of the Issuer's initial public offering at a conversion ratio of 1 share of common stock for every 7.5 shares of Series A preferred stock and Series B preferred stock, for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A preferred stock and Series B preferred stock converted upon the closing of the Issuer's initial public offering at a conversion ratio of 1 share of common stock for every 7.5 shares of Series A preferred stock and Series B preferred stock, for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A preferred stock and Series B preferred stock converted upon the closing of the Issuer's initial public offering at a conversion ratio of 1 share of common stock for every 7.5 shares of Series A preferred stock and Series B preferred stock, for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Lilly Ventures Fund I LLC (the \"Fund\"). Eli Lilly and Company, as sole Managing Member of the Fund, and pursuant to provisions of the LLC Agreement of the Fund, has voting authority with respect to shares owned by the Fund. S. Edward Torres, is a non-managing member of the Fund and may be deemed to beneficially own the shares. Mr. Torres disclaims beneficial ownership of the shares held of record by the Fund, except to the extent of his pecuniary interest therein. The attached Exhibit 99.1 lists details for each 10% and beneficial owner."}],"balance_after":0,"derivative":{"exercise_price":7.73,"underlying":"Common Stock","underlying_shares":672029},"source":{"system":"sec-edgar","filing":"0000059478-13-000082","document":"wf-form4a_138507260568530.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947813000082/wf-form4a_138507260568530.xml","form_type":"4/A","original_submission_date":"2013-05-14"}},{"id":178836,"issuer":{"id":12658,"kind":"organization","name":"Receptos, Inc.","symbol":"RCPT"},"owners":[{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY","position":1,"cik":"0000059478","reported_name":"LILLY ELI & CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12397,"kind":"organization","name":"Lilly Ventures Fund I LLC","position":2,"cik":"0001575852","reported_name":"Lilly Ventures Fund I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12659,"kind":"person","name":"Torres S. Edward","position":3,"cik":"0001552293","reported_name":"Torres S. Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2013-11-21T22:23:39.000Z","date":"2013-05-14","kind":"exercise","acquired":false,"price":0,"reported_value":8640289,"ownership":{"direct":false,"nature":"by Group"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Series A preferred stock and Series B preferred stock converted upon the closing of the Issuer's initial public offering at a conversion ratio of 1 share of common stock for every 7.5 shares of Series A preferred stock and Series B preferred stock, for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A preferred stock and Series B preferred stock converted upon the closing of the Issuer's initial public offering at a conversion ratio of 1 share of common stock for every 7.5 shares of Series A preferred stock and Series B preferred stock, for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A preferred stock and Series B preferred stock converted upon the closing of the Issuer's initial public offering at a conversion ratio of 1 share of common stock for every 7.5 shares of Series A preferred stock and Series B preferred stock, for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Lilly Ventures Fund I LLC (the \"Fund\"). Eli Lilly and Company, as sole Managing Member of the Fund, and pursuant to provisions of the LLC Agreement of the Fund, has voting authority with respect to shares owned by the Fund. S. Edward Torres, is a non-managing member of the Fund and may be deemed to beneficially own the shares. Mr. Torres disclaims beneficial ownership of the shares held of record by the Fund, except to the extent of his pecuniary interest therein. The attached Exhibit 99.1 lists details for each 10% and beneficial owner."}],"balance_after":0,"derivative":{"exercise_price":5.25,"underlying":"Common Stock","underlying_shares":1152039},"source":{"system":"sec-edgar","filing":"0000059478-13-000082","document":"wf-form4a_138507260568530.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947813000082/wf-form4a_138507260568530.xml","form_type":"4/A","original_submission_date":"2013-05-14"}},{"id":178835,"issuer":{"id":12658,"kind":"organization","name":"Receptos, Inc.","symbol":"RCPT"},"owners":[{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY","position":1,"cik":"0000059478","reported_name":"LILLY ELI & CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12397,"kind":"organization","name":"Lilly Ventures Fund I LLC","position":2,"cik":"0001575852","reported_name":"Lilly Ventures Fund I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12659,"kind":"person","name":"Torres S. Edward","position":3,"cik":"0001552293","reported_name":"Torres S. Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2013-11-21T22:23:39.000Z","date":"2013-05-14","kind":"purchase","acquired":true,"shares":142857,"price":14,"value":1999998.0,"ownership":{"direct":false,"nature":"by Group"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Lilly Ventures Fund I LLC (the \"Fund\"). Eli Lilly and Company, as sole Managing Member of the Fund, and pursuant to provisions of the LLC Agreement of the Fund, has voting authority with respect to shares owned by the Fund. S. Edward Torres, is a non-managing member of the Fund and may be deemed to beneficially own the shares. Mr. Torres disclaims beneficial ownership of the shares held of record by the Fund, except to the extent of his pecuniary interest therein. The attached Exhibit 99.1 lists details for each 10% and beneficial owner."}],"balance_after":2081210,"source":{"system":"sec-edgar","filing":"0000059478-13-000082","document":"wf-form4a_138507260568530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947813000082/wf-form4a_138507260568530.xml","form_type":"4/A","original_submission_date":"2013-05-14"}},{"id":178834,"issuer":{"id":12658,"kind":"organization","name":"Receptos, Inc.","symbol":"RCPT"},"owners":[{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY","position":1,"cik":"0000059478","reported_name":"LILLY ELI & CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12397,"kind":"organization","name":"Lilly Ventures Fund I LLC","position":2,"cik":"0001575852","reported_name":"Lilly Ventures Fund I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12659,"kind":"person","name":"Torres S. Edward","position":3,"cik":"0001552293","reported_name":"Torres S. Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2013-11-21T22:23:39.000Z","date":"2013-05-14","kind":"exercise","acquired":true,"shares":672029,"price":7.73,"value":5194784.17,"ownership":{"direct":false,"nature":"by Group"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Lilly Ventures Fund I LLC (the \"Fund\"). Eli Lilly and Company, as sole Managing Member of the Fund, and pursuant to provisions of the LLC Agreement of the Fund, has voting authority with respect to shares owned by the Fund. S. Edward Torres, is a non-managing member of the Fund and may be deemed to beneficially own the shares. Mr. Torres disclaims beneficial ownership of the shares held of record by the Fund, except to the extent of his pecuniary interest therein. The attached Exhibit 99.1 lists details for each 10% and beneficial owner."}],"balance_after":1938353,"source":{"system":"sec-edgar","filing":"0000059478-13-000082","document":"wf-form4a_138507260568530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947813000082/wf-form4a_138507260568530.xml","form_type":"4/A","original_submission_date":"2013-05-14"}},{"id":178833,"issuer":{"id":12658,"kind":"organization","name":"Receptos, Inc.","symbol":"RCPT"},"owners":[{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY","position":1,"cik":"0000059478","reported_name":"LILLY ELI & CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12397,"kind":"organization","name":"Lilly Ventures Fund I LLC","position":2,"cik":"0001575852","reported_name":"Lilly Ventures Fund I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12659,"kind":"person","name":"Torres S. Edward","position":3,"cik":"0001552293","reported_name":"Torres S. Edward","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2013-11-21T22:23:39.000Z","date":"2013-05-14","kind":"exercise","acquired":true,"shares":1152039,"price":5.25,"value":6048204.75,"ownership":{"direct":false,"nature":"by Group"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Lilly Ventures Fund I LLC (the \"Fund\"). Eli Lilly and Company, as sole Managing Member of the Fund, and pursuant to provisions of the LLC Agreement of the Fund, has voting authority with respect to shares owned by the Fund. S. Edward Torres, is a non-managing member of the Fund and may be deemed to beneficially own the shares. Mr. Torres disclaims beneficial ownership of the shares held of record by the Fund, except to the extent of his pecuniary interest therein. The attached Exhibit 99.1 lists details for each 10% and beneficial owner."}],"balance_after":1266324,"source":{"system":"sec-edgar","filing":"0000059478-13-000082","document":"wf-form4a_138507260568530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947813000082/wf-form4a_138507260568530.xml","form_type":"4/A","original_submission_date":"2013-05-14"}}]}